Clinical trial
Early Administration of L-carnitine in Hemodialysis Patients
NCT00322322 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00322322 |
|---|---|
| Title | Early Administration of L-carnitine in Hemodialysis Patients |
| Official title | Early Administration of L-carnitine in Hemodialysis Patients: Double Blind Randomized Trial Versus Placebo |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Complication of Hemodialysis, Hyperthyroidism Treated or Under Control |
| Intervention type | Drug |
| Interventions | L-Carnitine |
| Enrollment | 110 |
| Start date | Jun 1, 2006 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | May 5, 2006 |
| Last update posted | May 4, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: